KRISTALLINE FORMEN

Patent europeic · EP3515924 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3515924
Numer da la dumonda
EP17771436
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-09-2017
Publitgà
31-07-2019
Concedì
15-12-2021
La protecziun finescha il pli tard
20-09-2037
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
C07F 9/6558 (2006.01)
A61K 31/675 (2006.01)
A61P 9/00 (2006.01)
Prioritad
WO PCT/EP2016/072562 22.09.2016
Dumonda PCT
PCT/EP2017/073858 21.09.2017
Publicaziun PCT
WO2018/055016 29.03.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. 19-09-2025

    Transferì

    Owner
    Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123 Allschwil → Viatris Asia Pacific Pte. Ltd., 2 Shenton Way, #18-01, SGX Centre 1, Singapore 068804, Singapore
    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 19.09.2025

  4. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  5. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  6. 26-10-2022

    Midada

    Published in Swissreg on 26.10.2022

  7. 01-10-2022

    Midada

    Published in Swissreg on 01.10.2022

  8. 15-12-2021

    Concedì

    Published in Swissreg on 15.12.2021

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.